SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

AiXin Life International, Inc. – ‘8-K’ for 8/4/20

On:  Friday, 9/25/20, at 12:14pm ET   ·   For:  8/4/20   ·   Accession #:  1493152-20-18334   ·   File #:  0-17284

Previous ‘8-K’:  ‘8-K’ on / for 5/14/20   ·   Next:  ‘8-K’ on / for 10/27/20   ·   Latest:  ‘8-K’ on 4/25/23 for 4/18/23   ·   7 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/25/20  AiXin Life International, Inc.    8-K:8,9     8/04/20    6:257K                                   M2 Compliance LLC/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     17K 
 2: EX-10.1     Material Contract                                   HTML     31K 
 3: EX-10.2     Material Contract                                   HTML     26K 
 4: EX-10.3     Material Contract                                   HTML     12K 
 5: EX-10.4     Material Contract                                   HTML     16K 
 6: EX-14.1     Code of Ethics                                      HTML     59K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (date of earlies event reported): August 4, 2020

 

 

AIXIN LIFE INTERNATIONAL, INC.

(Exact name of registrant as specified in its charter)

 

Colorado   0-17284   84-1085935
State of   Commission   IRS Employer
Incorporation   File Number   Identification No.

 

Hongxing International Business Building 2, 14th FL, No. 69 Qingyun South Ave., Jinjiang District

Chengdu City, Sichuan Province, China

(Address of principal executive offices)

 

86-313-6732526

(Issuer’s telephone number)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

[  ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company [X]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

Securities registered pursuant to Section 12(b) of the Act: None

 

 

 

 C: 
 

 

 

Item 8.01 Other Events

 

On August 4, 2020, the Board of Directors of AiXin Life International, Inc.(the “Company”) established an Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee, each consisting of Chang-Ping Lin, Yuhua Zhu and Tao-Te Wang. Chang-Ping Lin is Chairman of the Audit Committee, Yuhua Zhu is Chairman of the Compensation Committee and Yao-Te is Chairman of the Nominating and Corporate Governance Committee. The Board also adopted a Code of Business Conduct and Ethics which is filed as Exhibit 14.1 to this report

 

On September 21, 2020, each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee adopted a charter, and the Board of Directors of the Company adopted a Whistleblower Policy, all of which are filed as exhibits to this report.

 

Item 9.01 Financial Statements and Exhibits

 

(c) Exhibits

Number

  Description
10.1   Audit Committee Charter
10.2   Compensation Committee Charter
10.3   Nominating and Corporate Governance Committee Charter
10.4   Whistleblower Policy
14.1   Code of Business Conduct and Ethics

 

 C: 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AiXin Life International, Inc.
     
Date: September 25, 2020 By: /s/ Quanzhong Lin
   

Quanzhong Lin

Chief Executive Officer

 

 C: 
 

 


Dates Referenced Herein

This ‘8-K’ Filing    Date    Other Filings
Filed on:9/25/20None on these Dates
9/21/20
For Period end:8/4/20
 List all Filings 


7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/09/24  AiXin Life International, Inc.    S-1/A                 87:14M                                    M2 Compliance LLC/FA
 7/25/23  AiXin Life International, Inc.    S-1/A                 85:12M                                    M2 Compliance LLC/FA
 6/26/23  AiXin Life International, Inc.    S-1/A                 85:12M                                    M2 Compliance LLC/FA
 4/05/23  AiXin Life International, Inc.    S-1/A                 86:12M                                    M2 Compliance LLC/FA
 3/07/23  AiXin Life International, Inc.    S-1/A       3/06/23   87:12M                                    M2 Compliance LLC/FA
 1/17/23  AiXin Life International, Inc.    S-1/A                 85:12M                                    M2 Compliance LLC/FA
11/04/22  AiXin Life International, Inc.    S-1                   86:12M                                    M2 Compliance LLC/FA
Top
Filing Submission 0001493152-20-018334   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 11:11:12.1am ET